Bleil Lynn Dorsey
SEC insider (Form 3/4/5 filer). CIK 0001607309. Director at AMICUS THERAPEUTICS, INC. (FOLD) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 27, 2026. Located in PRINCETON, NJ.
Companies Bleil Lynn Dorsey has filed insider reports for
- AMICUS THERAPEUTICS, INC. (FOLD): Director
- STERICYCLE INC (SRCL): Director
Bleil Lynn Dorsey
CIK: 0001607309
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
